Thyroid Histopathology, Cytology and Molecular Diagnosis in the NIFTP Era

Thyroid Histopathology, Cytology and Molecular Diagnosis in the NIFTP Era is organized by United States and Canadian Academy of Pathology (USCAP).

Original release date: October 21, 2017
Access expires: October 20, 2020, at 11:59 PM Pacific Time

Continuing Medical Education and Continuing Certification:
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 3 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

USCAP is approved by the American Board of Pathology (ABPath) to offer Self-Assessment credits (SAMs) and Lifelong Learning (Part II) credit for the purpose of meeting the ABPath requirements for Continuing Certification (CC). Registrants must take and pass the post-test in order to claim SAMs credit. Physicians can earn a maximum of 3 SAM/Part II credit hours.

Course Description:
Especially valuable to surgical pathologists and cytopathologists alike, the latest updates on noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) will help ensure that a subset of indolent thyroid tumors is managed more conservatively and spares patients the anxiety of a cancer diagnosis. The activity will help pathologists and cytopathologists minimize malignant diagnoses on cytology associated with a final diagnosis of NIFTP and identify potential NIFTPs in indeterminate aspirates to promote conservative surgical management.

Learning Objectives:
Upon completion of this educational activity, learners will be able to:
• Learn to accurately render a diagnosis of NIFTP and recognize NIFTP mimics
• Learn how NIFTP affects the risk of malignancy for Bethesda diagnostic categories
• Learn how to diagnose potential NIFTPs on cytology within the framework of the Bethesda system
• Learn how NIFTP will affect the results of molecular testing of thyroid nodules